35 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
-K, in our press releases, in our presentations, on our website and in other materials released to the public. Any or all of the forward-looking
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
-K, in our press releases, in our presentations, on our website and in other materials released to the public. Any or all of the forward-looking
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
materials released to the public. Any or all of the forward-looking statements included in this Report and in any other reports or public statements
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
materials for compounds approved under accelerated regulations are subject to prior review by the FDA. In addition, the FDA generally requires … , as a condition for Accelerated Approval, that all advertising and promotional materials intended for dissemination or publication within 120 days
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
materials for compounds approved under accelerated regulations are subject to prior review by the FDA. In addition, the FDA generally requires … , as a condition for Accelerated Approval, that all advertising and promotional materials intended for dissemination or publication within 120 days
10-K
ft8geljl33tsfbf84n
16 Apr 24
Annual report
4:48pm
8-K
fpvdp4tviuwqesh9hwx6
13 Mar 24
Regulation FD Disclosure
8:00am
8-K
EX-1.1
0tceomy93ltgvvews5qk
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
8-K
EX-3.2
qo7843y
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
h4irdax9wsal ftks
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
0zx1jhp8japizxzlnl
20 Feb 24
Prospectus supplement with pricing info
5:28pm